Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Aslan Pharmaceuticals Ltd ADR (NQ: ASLN )

2.500 USD +0.430 (+20.77%)
Official Closing Price Updated: 7:59 PM EST, Jan 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,082,400
Open 2.260
Bid (Size) 2.510 (7)
Ask (Size) 2.540 (12)
Prev. Close 2.070
Today's Range 2.120 - 2.550
52wk Range 0.8300 - 2.550
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
New Research Published in Toxicology in Vitro Provides Insight Into the Hepatotoxicity of DHODH Inhibitors Suggesting ASLAN003 Has the Potential to Be Best-In-Class
From GlobeNewswire News Releases
ASLAN Pharmaceuticals Opens Expansion Cohort in ASLAN004 Atopic Dermatitis Clinical Trial
From GlobeNewswire News Releases

Performance

YTD
+34.41%
+34.41%
1 Month
+30.21%
+30.21%
3 Month
+46.20%
+46.20%
6 Month
+47.06%
+47.06%
1 Year
+17.92%
+17.92%

More News

Read More
ASLAN Pharmaceuticals to Present at Upcoming Piper Sandler Investor Conference
From GlobeNewswire News Releases
ASLAN Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Corporate Update
From GlobeNewswire News Releases
ASLAN Pharmaceuticals Initiates Third Dose Cohort of ASLAN004 in Atopic Dermatitis Clinical Trial
From GlobeNewswire News Releases
ASLAN Pharmaceuticals to Develop ASLAN003 as Next Generation DHODH Inhibitor in Autoimmune Conditions
From GlobeNewswire News Releases
ASLAN Pharmaceuticals Completes Enrolment in Second Cohort and Opens New Sites in US and Australia in ASLAN004 Atopic Dermatitis Study
From GlobeNewswire News Releases
12 Health Care Stocks Moving In Tuesday's Intraday Session
Tags VIR GRTS BZI/TFM
From Benzinga
ASLAN Pharmaceuticals to Present at H.C. Wainwright 22nd Annual Global Investment Conference
From GlobeNewswire News Releases
ASLAN Pharmaceuticals Resumes Recruitment of New Patients Into ASLAN004 Study
From GlobeNewswire News Releases
12 Health Care Stocks Moving In Friday's Pre-Market Session
Tags Benzinga Movers HGEN
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.